Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;7(1):16-22.
doi: 10.5009/gnl.2013.7.1.16. Epub 2012 Dec 5.

A Study on the Efficacy of Proton Pump Inhibitors in Helicobacter pylori-Negative Primary Care Patients with Dyspepsia in Japan

Affiliations

A Study on the Efficacy of Proton Pump Inhibitors in Helicobacter pylori-Negative Primary Care Patients with Dyspepsia in Japan

Tomoari Kamada et al. Gut Liver. 2013 Jan.

Abstract

Background/aims: There have been few studies on the efficacy of proton pump inhibitors and the doses required to treat dyspeptic symptoms observed in clinical practice. The aim of this study was to compare the efficacy of different doses of omeprazole and different administration methods in Helicobacter pylori-negative, dyspeptic patients.

Methods: Patients with chronic upper abdominal symptoms within the previous 3 months were randomly divided into three groups: a daily, omeprazole 20 mg treatment group (OPZ20, n=61); a daily, omeprazole 10 mg treatment group (OPZ10, n=72); and an on-demand omeprazole 20 mg treatment group (on-demand, n=62). After 4 weeks of administration of the drug, symptom improvement rates were evaluated based on the Overall Global Severity score.

Results: The rates of symptom improvement after 4 weeks of treatment were 65.6% (40/61) in the OPZ20 group, 47.2% (34/72) in the OPZ10 group, and 50.0% (31/62) in the on-demand group. The OPZ20 group exhibited a significantly higher improvement rate (p=0.034) than the OPZ10 group. The OPZ20 group had significant improvements in regurgitation, postprandial fullness, vomiting, and bloating compared with the OPZ10 group.

Conclusions: Daily treatment with 20 mg of omeprazole was efficient in treating upper abdominal symptoms.

Trial registration: ClinicalTrials.gov, number UMIN000002621.

Keywords: Dyspepsia; Omeprazole; Primary health care; Proton pump inhibitors.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1
Flow diagram of study patients. GOS, Global Overall Symptom; OPZ, omeprazole.
Fig. 2
Fig. 2
Frequency of symptoms in each treatment group at baseline. The main bothersome symptoms were postprandial fullness, bloating, and stomach pain.
Fig. 3
Fig. 3
Percentage of patients exhibiting sufficient symptom relief after 4 weeks of treatment. The omeprazole (OPZ)20 group exhibited significantly better results than the OPZ10 group (p<0.05) with respect to the primary outcome measure of symptom relief (Global Overall Symptom ≤2).

References

    1. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut. 1999;45(Suppl 2):II37–II42. - PMC - PubMed
    1. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479. - PubMed
    1. Kawamura A, Adachi K, Takashima T, et al. Prevalence of functional dyspepsia and its relationship with Helicobacter pylori infection in a Japanese population. J Gastroenterol Hepatol. 2001;16:384–388. - PubMed
    1. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST) Scand J Gastroenterol Suppl. 1999;231:20–28. - PubMed
    1. Jones RH, Lydeard SE, Hobbs FD, et al. Dyspepsia in England and Scotland. Gut. 1990;31:401–405. - PMC - PubMed

LinkOut - more resources